Microbiology: Current Research

All submissions of the EM system will be redirected to Online Manuscript Submission System. Authors are requested to submit articles directly to Online Manuscript Submission System of respective journal.
Reach Us +1-845-208-9209

Perspective - Microbiology: Current Research (2022) Volume 6, Issue 5

Microbial co-infections and antibiotic resistance in patients with COVID-19

The novel coronavirus infectious disease 2019 (Coronavirus), brought about by extreme intense respiratory disorder Covid 2 (SARS-CoV-2) has damaged the entire world with the continuous crushing pandemic. A plenty of microbial spaces including infections (other than SARS-CoV-2), microscopic organisms, archaea and parasites have developed together, and collaborate in complex sub-atomic pathogenesis alongside SARS-CoV-2. In any case, the association of other microbial co-microorganisms and hidden atomic systems prompting exploitative disease in fundamentally sick Coronavirus patients has yet not been broadly evaluated. Albeit, the rate of co-diseases could depend on 94.2% in research facility affirmed Coronavirus cases, the destiny of co-diseases among SARS-CoV-2 tainted has frequently relies upon the harmony between the host's defensive resistance and immunopathology. Prevalently distinguished co-microorganisms of SARS-CoV-2 are microbes, for example, Streptococcus pneumoniae, Staphylococcus aureus, Klebsiella pneumoniae, Haemophilus influenzae, Mycoplasma pneumoniae, Acinetobacter baumannii, Legionella pneumophila and Clamydia pneumoniae followed by infections including flu, Covid, rhinovirus/enterovirus, parainfluenza, metapneumovirus, flu B infection, and human immunodeficiency infection. The cross-talk between co-microorganisms (particularly lung microbiomes), SARS-CoV-2 and host is a significant variable that eventually builds the trouble of finding, treatment, and prognosis of COVID-19.

Author(s): Israt Hossain

Abstract Full Text PDF

Get the App